Vivani Medical & Okava Pharmaceuticals Extend Collaboration to Develop OKV-119 for Canine Cardiometabolic Diseases
Shots: Vivani Medical & Okava Pharmaceuticals have expanded their 2019 collabo...
Shots: Vivani Medical & Okava Pharmaceuticals have expanded their 2019 collabo...
Shots: The US FDA has approved label expansion of Simparica Trio to protect dogs a...
Shots: OS Therapies has reported data from 2 studies assessing OST-HER2 with palli...
Shots: Spirited Paw (Standard Process' Brand) has launched Calm supplement to...
Shots: Zoetis has reported the self-sponsored UK trial data on Librela (bedinvetma...
Shots: The USDA CVB has fully approved ELIAS Cancer Immunotherapy (ECI) for the tr...
Incisive News in 3 Shots.
Modal body text goes here.